JMJD5 also displays striking tissue-specific duality in cancer: it is frequently overexpressed and acts as an oncogene in breast, prostate, and oral squamous cell carcinomas, yet is downregulated and functions as a tumor suppressor in lung, hepatocellular, and pancreatic cancers. Here, KDM8 is linked to cancer.